The invention concerns compounds having antiviral activity, in particular having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising these compounds and the compounds for use in the treatment or prevention of respiratory syncytial virus infection.
superconducting state at 0.066°K in the metallic compound Ag2F. Though the crystal structure of Ag2F suggests that it is a metal in two dimensions and an insulator in the third, measurement of the Meissner effect in single crystals demonstrates that supercurrents flow in all three directions. The electronic specific heat coefficient of Ag2F calculated from the superconducting critical field is 0.62